IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Nextech Invest Ltd.

Portfolio Profile

CIK: 0001595430 | Zurich, V8

Investment Profile

Style

Deep Value

Turnover

Low

Orientation

Concentrated long-term
$2.1B
AUM
15
Positions
98.01%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Revolution Medicines Inc(RVMD)7,601,087$1.4B67.55%
2Parabilis Medicines Inc(PBLS)4,663,176$127.6M6.06%
3Relay Therapeutics Inc(RLAY)6,776,506$126.8M6.02%
4Tyra Biosciences Inc(TYRA)3,553,585$113.5M5.39%
5Alumis Inc(ALMS)3,540,998$99.6M4.73%

Sector Allocation

Latest filing, equity positions only

Healthcare93.94% · $2.0B
Unclassified6.06% · $127.6M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare100%93.94%-6.06%
Unclassified0%6.06%+6.06%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$430.3M | 15 pos.
$528.4M | 16 pos.
$657.0M | 15 pos.
$1.0B | 16 pos.
$1.4B | 17 pos.
$2.1B | 16 pos.
6
Oric Pharmaceuticals Inc(ORIC)
7,162,637
$77.6M
3.68%
7Kymera Therapeutics Inc(KYMR)278,896$32.0M1.52%
8Zymeworks Inc(ZYME)1,113,946$29.1M1.38%
9Monte Rosa Therapeutics Inc(GLUE)761,153$18.4M0.87%
10Arvinas Inc(ARVN)1,122,713$17.1M0.81%
Cap SizePrev %Curr %Change
Large Cap52.02%67.55%+15.53%
Small Cap17.86%14.37%-3.49%
Mid Cap28.75%11.63%-17.12%
Unclassified0%6.06%+6.06%
Micro Cap1.37%0.39%-0.98%
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

1
New
3
Closed
3
Increased
1
Decreased
10
Unchanged